Global Hormone Replacement Therapy Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 69

Global Hormone Replacement Therapy Market 2015-2019

Covering: An in-depth study of the global hormone replacement therapy market and segmentation by type of hormonal therapy (estrogen replacement therapy and growth hormone replacement therapy), by route of administration (oral, parenteral, and transdermal), and by geography (the Americas, EMEA, and APAC). The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market, including F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer.

An overview of the hormone replacement therapy market

Hormone replacement therapy involves the replacement of the hormones in the body whose levels have become low, in case of women nearing menopause or patient with growth hormone deficiency due to conditions such as dwarfism. At present, the combination of drugs are used to treat the conditions, which are known to have a better safety and efficacy parameter. Unmet medical needs is one of the major drivers influencing the growth of the market. Therefore, the need for new treatment options with better safety results to accommodate the current unmet need is huge.

In 2014, the Americas dominated the market, where the majority of the contribution was from the US, and this trend is expected to continue during the forecast period. However, the market in the APAC region is witnessing a rapid growth, hence, there is a vast opportunity for vendors to venture into this region. The expects the global hormone replacement therapy market to grow at a moderate rate, posting a CAGR of over 2% during the forecast period.

Segmentation of the hormone replacement therapy market by type of hormonal therapy

  • Estrogen replacement therapy
  • Growth hormone replacement therapy

With a market share of more than 60% the estrogen replacement therapy segment dominate the hormone replacement therapy market. Estrogen replacement therapy is a type of therapy in which estrogen hormones are commonly used to treat the symptoms of menopause. It helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness.

Segmentation of the hormone replacement therapy market by route of administration

  • Oral
  • Parenteral
  • Transdermal

The oral route of administration is a sub-division of enteral administration and is regarded as one of the safest and most preferred routes of drug administration. Some of the drug that are administered orally are Premarin and Estrace.

Competitive landscape and key vendors

The global hormone replacement therapy market is a mature market, which is extremely competitive due to the presence of a huge number of small and large vendors. Therefore, development of low-dose oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected to captivate the attention of players in the hormonal replacement market.

Key vendors in this market are -

  • F. Hoffmann-La Roche
  • Merck Serono
  • Novartis
  • Novo Nordisk
  • Pfizer

Other prominent vendors included in this report are Abbott Laboratories, Amgen, ANI Pharmaceuticals, Bayer, Eli Lilly, Hisamitsu Pharmaceutical, Ipsen, Merck, Mylan Laboratories, Orion, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries, and Therapeutics MD.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global hormone replacement therapy market?
  • What are the key market trends impacting the growth of the global hormone replacement therapy market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global hormone replacement therapy market?
  • What are the market opportunities and threats faced by the vendors in the global hormone replacement therapy market?
  • What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
  • What are the key outcomes of the five forces analysis of the global hormone replacement therapy market?
Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Filtration Paper Market 2017-2021

Filtration, a technique used to separate solids from liquids, is the act of pouring a mixture onto a membrane (filter paper) that allows the passage of liquid (the filtrate) and results in the collection of the solid. The analysts forecast the global filtration paper market to grow at a CAGR of 4.16% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global filtration paper market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of filter papers. The market is divided into the following segments based on geography: APAC Europe North America ROW The report, Global Filtration Paper Market 2017-2021, has been prepared based on an in-depth mark......
$3500

Global Healthcare Cloud Computing Market 2017-2021

Cloud computing helps enterprises effectively reduce their capital and operational costs. It is gaining traction in the global healthcare industry as organizations are adopting an information-centric business approach. The demand for on-premises software solutions in the healthcare industry has receded due to the growing adoption of cloud-based solutions. Polycom, a US-based firm that manufactures video conferencing equipment, is offering cloud-based on-demand video conferencing solutions that help reduce on-premises infrastructure costs. Cloud-based telehealth services eliminate the need to install hardware and other infrastructure that is set up in hospitals and telecardiology centers. The analysts forecast global healthcare cloud computing market to grow at a CAGR of 21.24% during th......
$3500

Global Diabetic Therapeutic Market 2017-2021

The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year. The analysts forecast the global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes.......
$3500

Global Coagulation Testing Market 2017-2021

Coagulation testing helps measure the ability of blood to form a clot. Clotting occurs when blood converts from liquid to gel form. Coagulation tests are performed to analyze clotting disorders, such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving the quality of life of patients. The analysts forecast the global coagulation testing market to grow at a CAGR of 6.43% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global coagulation testing market for 2017-2021. To calculate the market size, the ......
$3500

Global MRSA Testing Market 2017-2021

MRSA has been a major cause of concern due to the long-term use of antibiotics, which is now deemed as unnecessary. The inappropriate use of antibiotics may contribute to the rise in drug-resistant bacteria because they do not destroy the bacteria completely. This has been one of the major factors influencing the use of MRSA testing in the medical industry. With this, there is focus on the development of rapid MRSA testing products with greater sensitivity for detection. The analysts forecast the global MRSA testing market to grow at a CAGR of 11.09% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global MRSA testing market for 2017-2021. To calculate the market size, the report considers the new installat......
$3500

Global Atopic Dermatitis Drugs Market 2017-2021

Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever), and chronic dermatitis. In this condition, the skin becomes extremely itchy and inflamed, which causes redness, cracking, weeping, swelling, vesicle formation, crushing, and scaling. Atopic dermatitis is very common worldwide, and its prevalence rate is increasing. The data estimates suggest that nearly 60% of the patients develop symptoms in the first year of life, and 88%-92% develop symptoms before the age of five. The analysts forecast the global atopic dermatitis drugs market to gro......
$3500

Global Pharmaceutical Excipients Market 2017-2021

About Pharmaceutical Excipients Pharmaceutical excipients are inert substances that are generally used to manufacture different forms of drugs and are present in the finished products. Excipients help in providing long-term stability and make solid formulations bulkier. They also improve the functionality of drugs and make them safer. The analysts forecast global pharmaceutical excipients market to grow at a CAGR of 6.53% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global pharmaceutical excipients market for 2017-2021. To calculate the market size, the report considers the sales of pharmaceutical excipients based on their functionalities, which include binders and fillers, coating agents, disintegrant......
$3500

Global Critical Care Therapeutics Market 2017-2021

About Critical Care Therapeutics Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume. The analysts forecast global critical care therapeutics market to grow at a CAGR of 3.62% during the period 201......
$3500

Global Pharmerging Markets 2017-2021

The immense growth potential in pharmerging market has driven large multinational pharmaceutical companies to focus on these regions by pursuing organic as well as in-organic routes. To make in-roads into the new geography, the large players usually take in-organic route through strategic expansion initiatives such as acquisitions and alliances. For instance, in December 2015, AstraZeneca entered into a deal with WuXi to acquire its biologics manufacturing facilities in China to expand locally. The analysts forecast global pharmerging market to grow at a CAGR of 12.88% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global pharmerging market for 2017-2021. To calculate the market size, the report considers......
$3500

Global Myasthenia Gravis Drugs Market 2017-2021

Currently, the myasthenia gravis drugs market stands at a small size due to limited availability of approved therapies for the complete remission of the disease. However, the anticipated approval of novel drugs such as monoclonal antibodies should help market witness strong growth during the forecast period. For instance, Alexion Pharmaceuticals is currently developing a monoclonal antibody, Soliris, for the treatment of myasthenia gravis. Once launched around end 2017 or beginning of 2018, this drug is expected to be the blockbuster drug for the market. The analysts forecast global myasthenia gravis drugs market to grow at a CAGR of 13.16% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global myasthenia ......
$3500